Current through October 31, 2024
This subpart sets forth the requirements relating to the following:
(a) Drug utilization management programs, quality assurance measures and systems, and MTM programs for Part D sponsors.(b) Appropriate dispensing of prescription drugs in long-term care facilities under PDPs and MA-PD plans.(c) Consumer satisfaction surveys of Part D plans.(d) Electronic prescription drug programs for prescribers, dispensers, and Part D sponsors.(e) Quality improvement organization (QIO) activities.(f) Compliance deemed on the basis of accreditation.(g) Accreditation organizations.(h) Procedures for the approval of accreditation organizations as a basis for deeming compliance. 70 FR 4525 , Jan. 28, 2005, as amended at 70 FR 67593 , Nov. 7, 2005; 76 FR 21573 , Apr. 15, 2011